ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Income Statement 2017–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenue | 27.6M | 26.5M | 17.5M | 18.6M | 19.2M | 15.3M | 13.7M | 11.0M | 10.4M |
| Gross Profit | 11.4M | 7.9M | 3.9M | 7.6M | 8.7M | 6.9M | 6.7M | 5.2M | 5.2M |
| Profitability | |||||||||
| Operating Income | 1.6M | -1.6M | -5.7M | -2.3M | 257,385 | -1.4M | -953,908 | -1.4M | -242,845 |
| EBITDA | 4.4M | 1.1M | — | — | — | — | — | — | — |
| Net Income | -1.0M | -2.2M | -5.8M | -2.5M | -78,292 | -1.0M | -1.3M | -2.3M | -168,147 |
| Per Share Data | |||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 9M | 8M | 8M | 8M | 8M | 7M | 7M | 5M | 5M |
ImmuCell Corporation Income Statement — FAQ
ImmuCell Corporation (ICCC) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's income statement history?
The chart and table above show ImmuCell Corporation's income statement by year and by quarter, including the growth rate.